My GP has told me categorically that I have T2 diabetes and that I ought to be taking Metformin. My last HbA1C was 48 mmol/mol. I am 59, weigh 11st 1lb and stand 5'7". Scared my this, I paid for a full heart scan that revealed 0 calcification. I am physically fit and experience none of the "traditional" symptoms of T2. There is no known history of diabetes in my family.
Research published in the BMJ in April 2013 (copy attached) says "current guidelines usually recommend a general target HbA1c of 53mmol/mol [7%] or less"
The same paper also says "HbA1c is not a substitute for postprandial measurements or assessment of hypoglycaemia. This surrogate measure has been used to support a treatment strategy that has helped to get drugs licensed, driven guideline development and even determined the amount that GPs get paid (emphasis added). For example, for 2012/13, the primary care Quality and Outcomes Framework (QOF) allocated points for achieving three levels of glucose control in people with type 2 diabetes: HbA1c of IFCC 59mmol/mol [7.5%]i or less, 64mmol/mol [8%] or less, and 75mmol/mol [9%] or less in the preceding 15 months"
All things considered, I am deeply sceptical about my own diagnosis and more importantly wonder how many other people are unnecessarily prescribed powerful chemicals at enormous cost to the NHS.
Is it possible that the "explosion of T2" that we read so much about is partially due to moving the goalposts since 2013? Looks like it to me.
Sceptical
Research published in the BMJ in April 2013 (copy attached) says "current guidelines usually recommend a general target HbA1c of 53mmol/mol [7%] or less"
The same paper also says "HbA1c is not a substitute for postprandial measurements or assessment of hypoglycaemia. This surrogate measure has been used to support a treatment strategy that has helped to get drugs licensed, driven guideline development and even determined the amount that GPs get paid (emphasis added). For example, for 2012/13, the primary care Quality and Outcomes Framework (QOF) allocated points for achieving three levels of glucose control in people with type 2 diabetes: HbA1c of IFCC 59mmol/mol [7.5%]i or less, 64mmol/mol [8%] or less, and 75mmol/mol [9%] or less in the preceding 15 months"
All things considered, I am deeply sceptical about my own diagnosis and more importantly wonder how many other people are unnecessarily prescribed powerful chemicals at enormous cost to the NHS.
Is it possible that the "explosion of T2" that we read so much about is partially due to moving the goalposts since 2013? Looks like it to me.
Sceptical